Rader Lab

Rader Lab

Dr. Janet Rader, Professor and Chair of the OBGYN Department, has great interest in the care of women and research. Dr. Rader has a dedicated space in the Human and Molecular Genetics Center (HMGC) to further her research along with scientists, PhDs, RNs, technicians and data analysts.

Infection with high-risk human papillomavirus (HPV) is the primary cause of cervical cancer, but it is evident that additional factors must be involved, since only a small proportion of infected women develop cancer. The laboratory concentrates on identifying genes involved in the progression of cervical cancer through the analysis of molecular changes in preinvasive and invasive neoplasias of the cervix, in addition to identifying host genetic susceptibility polymorphisms in the progression of disease.

Through a candidate gene approach that uses family-based controls, we identify inherited genetic polymorphisms and high-risk HPV subtypes/variants that contribute to the development of invasive cervical cancer and high-grade cervical intraepithelial neoplasia. The ongoing investigation is known as the Cervical Cancer Genetic Epidemiology (CerGE) study. We have DNA from cancer patients and family-based controls (trios), and have typed HPVs in tumors of affected women. To date, we have identified significant genetic polymorphisms in several candidate genes that associate with disease.

Future goals are to accelerate the identification of polymorphisms important in the host susceptibility to cervical cancer utilizing high-throughput genotyping and candidate gene sequencing. We will identify the causal basis of the variants by interrogating matched cancer samples and functional assays.

Through a candidate gene approach that uses family-based controls, we identify inherited genetic polymorphisms and high-risk HPV subtypes/variants that contribute to the development of invasive cervical cancer and high-grade cervical intraepithelial neoplasia. The ongoing investigation is known as the Cervical Cancer Genetic Epidemiology (CerGE) study. We have DNA from cancer patients and family-based controls (trios), and have typed HPVs in tumors of affected women. To date, we have identified significant genetic polymorphisms in several candidate genes that associate with disease.

Froedtert Today - January, 2011

As seen in: Froedtert Today – January, 2011
Download the Full PDF

Future goals are to accelerate the identification of polymorphisms important in the host susceptibility to cervical cancer utilizing high-throughput genotyping and candidate gene sequencing. We will identify the causal basis of the variants by interrogating matched cancer samples and functional assays.

We want to understand why a small number of those exposed to HPV go on to get cancer.

Women who have been treated for cervical cancer may be eligible for a current study on genetic susceptibility to that cancer. Exposure to the human papillomavirus (HPV) can lead to cervical cancer, but it doesn’t always. “We want to understand why a small number of those exposed to HPV go on to get cancer,” said Janet Rader, MD, a Medical College of Wisconsin gynecologic oncologist, chair of the Department of Obstetrics and Gynecology and the study’s principal investigator.

The CerGE study, as it is called, has nothing to do with the patient’s treatment for cervical cancer. It is aimed at understanding both the HPV’s genetic variations and genetic variations in the patient that may cause cancer to develop in one person, but not another. As part of the study, Dr. Rader explained, the team also collects blood from the patient’s mother and father to examine which genetic variations the patient inherited and which variations they did not. The study’s results could help develop better testing for cervical cancer. Dr. Rader is especially interested in patients who have another first-degree relative — a mother or a sister — who also has been treated for cervical cancer. Please see more information on Dr. Rader’s lab.

More Information

For information on the CerGE research study, please contact the research team at 1-855-771-9477 or Email Us.

Principal Investigator

Janet S. Rader, MD

Rader, Janet S., MD

Chairman; Jack A. & Elaine D. Klieger ProfessorSpecialty: Gynecologic Oncology

Read More ›

Research Scientist

Iden, Marissa, PhD

Iden, Marissa, PhD

Research Scientist – Dr. Rader’s Lab
(414) 955-7413

Read More ›

In the News

Rounding with the Dean: Knowledge Changing Life in the Department of Obstetrics & Gynecology

Rounding with the Dean: Knowledge Changing Life in the Department of Obstetrics & Gynecology

Josepah E. Kerschner, MD

On October 4, 2017, Josepah E. Kerschner, MD, Dean of the School of Medicine at the Medical College… Read More ›

Surviving and Thriving with Gynecologic Cancer: The Word on Medicine Podcast

Surviving and Thriving with Gynecologic Cancer: The Word on Medicine Podcast

Our gynecologic oncology team of providers shares information on “Surviving and Thriving with Gynecologic Cancer”.

Read More ›

Dr. Janet S. Rader - Study Author of Integrated Genomic and Molecular Characterization of Cervical Cancer

Dr. Janet S. Rader – Study Author of Integrated Genomic and Molecular Characterization of Cervical Cancer

03/24/2017  |  Department News, Research News

Janet Rader, MD

Corresponding author and co-Chair Janet S. Rader, MD and contributors Denise Uyar, MD, William Bradley, MD and Behnaz Behmaram,… Read More ›

Ovarian Cancer Research has Champion in the William and Sandy Heitz Family Foundation

Ovarian Cancer Research has Champion in the William and Sandy Heitz Family Foundation

09/10/2013  |  Department News, Research News

A family that has been affected by cancer several times over is making significant contributions to the advancement of more effective therapies for ovarian cancer… Read More ›

Treatment Starts with the Right Diagnosis and Comprehensive Choices

Treatment Starts with the Right Diagnosis and Comprehensive Choices

08/26/2013  |  Department News, Research News

As seen in: Clinical Cancer Center Special Report 2013: The Cancer ResearcherDownload the Full Report

Not all gynecologic cancers are the same…. Read More ›

Froedtert & The Medical College of Wisconsin elevated to full member of Gynecologic Oncology Group

Froedtert & The Medical College of Wisconsin elevated to full member of Gynecologic Oncology Group

08/12/2013  |  Department News, Research News

Froedtert & The Medical College of Wisconsin have been elevated to full membership in the Gynecologic Oncology Group (GOG), a National Cancer Institute (NCI)-funded cooperative… Read More ›

Almost All Endometrial Cancer Treated Robotically at Froedtert & the Medical College

Almost All Endometrial Cancer Treated Robotically at Froedtert & the Medical College

04/03/2012  |  Department News, Research News

As seen in: Clinical Cancer Center Special Report 2012: Defining the FutureDownload the Full Report

“During the last several years, minimally invasive… Read More ›

Mobile TRU

Global Research Effort Explores Genetics of Obesity

12/07/2011  |  Department News, Research News

Researchers at The Medical College of Wisconsin are national leaders on the genetic basis of obesity. They made a landmark discovery that uncovered a genetic… Read More ›

Nature - June 2011

Dr. Janet S. Rader one of the Study Authors of Integrated Genomic Analyses of Ovarian Carcinoma

07/18/2011  |  Department News, Research News

Janet Rader, MD, Chairman and the Jack A. & Elaine D. Klieger Professor of Obstetrics and Gynecology, is one of the study authors of a paper… Read More ›

Volunteers Needed for Cervical Cancer Study

Volunteers Needed for Cervical Cancer Study

06/20/2011  |  Department News, Research News

Volunteers are needed for a study to identify genetic risk factors for cervical cancer. You may be eligible to participate if you have a personal history of invasive cervical cancer or pre-invasive cervical cancer (CIN3 or severe dysplasia).

Read More ›

Individualized Treatment for Ovarian Cancer

Individualized Treatment for Ovarian Cancer

05/01/2011  |  Department News, Research News

As seen in: Froedtert Today, May, 2011Download the Full PDF

About 500 women are diagnosed with ovarian cancer annually in Wisconsin. Even… Read More ›

Study Looks at Genetics and Cervical Cancer

Study Looks at Genetics and Cervical Cancer

01/13/2011  |  Department News, Research News

As seen in: Froedtert Today – January, 2011Download the Full PDF

Women who have been treated for cervical cancer may be eligible… Read More ›